{
  "ticker": "IRWD",
  "company_name": "Ironwood Pharmaceuticals, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT01712412",
      "title": "Phase 2a Study of IW-9179 to Treat Functional Dyspepsia",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "Dyspepsia, Functional Gastrointestinal Disorders",
      "start_date": "2012-10",
      "completion_date": "2014-03",
      "enrollment": 0,
      "sponsor": "Ironwood Pharmaceuticals, Inc."
    },
    {
      "nct_id": "NCT02030925",
      "title": "Ph2a Study to Evaluate IW-3718 in Patients With Gastroesophageal Reflux Not Completely Responsive to Proton Pump Inhibitors",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Gastroesophageal Reflux",
      "start_date": "2014-02",
      "completion_date": "2014-12",
      "enrollment": 0,
      "sponsor": "Ironwood Pharmaceuticals, Inc."
    },
    {
      "nct_id": "NCT02559817",
      "title": "A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "Irritable Bowel Syndrome With Constipation",
      "start_date": "2015-11-01",
      "completion_date": "2019-08-30",
      "enrollment": 0,
      "sponsor": "Forest Laboratories"
    },
    {
      "nct_id": "NCT02291679",
      "title": "Trial of Linaclotide in Patients With Chronic Idiopathic Constipation",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Chronic Idiopathic Constipation",
      "start_date": "2014-10",
      "completion_date": "2015-08",
      "enrollment": 0,
      "sponsor": "Ironwood Pharmaceuticals, Inc."
    },
    {
      "nct_id": "NCT02289846",
      "title": "Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP)",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Diabetic Gastroparesis",
      "start_date": "2014-10",
      "completion_date": "2015-12",
      "enrollment": 0,
      "sponsor": "Ironwood Pharmaceuticals, Inc."
    },
    {
      "nct_id": "NCT03226899",
      "title": "A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment",
      "status": "TERMINATED",
      "phase": "PHASE4",
      "condition": "Gout, Chronic Kidney Disease (CKD)",
      "start_date": "2017-07-19",
      "completion_date": "2019-02-25",
      "enrollment": 0,
      "sponsor": "Ironwood Pharmaceuticals, Inc."
    },
    {
      "nct_id": "NCT05760313",
      "title": "A Study to Assess Adverse Events and Change in Disease Activity in Pediatric Participants (Age 6 Months to <2 Years) With Functional Constipation Who Are Treated With Linaclotide",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Functional Constipation",
      "start_date": "2023-04-27",
      "completion_date": "2025-06-09",
      "enrollment": 0,
      "sponsor": "AbbVie"
    },
    {
      "nct_id": "NCT00730171",
      "title": "An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Irritable Bowel Syndrome With Constipation, Chronic Constipation",
      "start_date": "2008-09",
      "completion_date": "2012-03",
      "enrollment": 0,
      "sponsor": "Ironwood Pharmaceuticals, Inc."
    },
    {
      "nct_id": "NCT03931785",
      "title": "A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Irritable Bowel Syndrome With Diarrhea (IBS-D)",
      "start_date": "2019-05-01",
      "completion_date": "2020-03-11",
      "enrollment": 0,
      "sponsor": "Ironwood Pharmaceuticals, Inc."
    },
    {
      "nct_id": "NCT02270983",
      "title": "Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Opioid-Induced Constipation",
      "start_date": "2014-10-31",
      "completion_date": "2015-10-31",
      "enrollment": 0,
      "sponsor": "Forest Laboratories"
    }
  ],
  "summary": {
    "total_trials": 42,
    "by_phase": {
      "PHASE2": 18,
      "PHASE3": 15,
      "PHASE4": 3,
      "PHASE1": 3,
      "NA": 3
    },
    "by_status": {
      "TERMINATED": 6,
      "COMPLETED": 35,
      "RECRUITING": 1
    },
    "active_trials": 1,
    "completed_trials": 35,
    "conditions": [
      "Chronic Constipation",
      "Chronic Constipation, Constipation",
      "Chronic Constipation, Irritable Bowel Syndrome With Constipation",
      "Chronic Idiopathic Constipation",
      "Constipation",
      "Diabetic Gastroparesis",
      "Dyspepsia, Functional Gastrointestinal Disorders",
      "Functional Constipation",
      "Functional Constipation (FC), Chronic Idiopathic Constipation (CIC)",
      "Functional Constipation in Children Ages 6-17 Years",
      "Functional Constipation, Irritable Bowel Syndrome With Constipation",
      "Gastroesophageal Reflux",
      "Gastroesophageal Reflux Disease",
      "Gastroesophageal Reflux Disease (GERD)",
      "Gout, Chronic Kidney Disease (CKD)",
      "Healthy",
      "Healthy Volunteers",
      "Hypercholesterolemia",
      "Interstitial Cystitis, Bladder Pain Syndrome",
      "Irritable Bowel Syndrome",
      "Irritable Bowel Syndrome Characterized by Constipation",
      "Irritable Bowel Syndrome With Constipation",
      "Irritable Bowel Syndrome With Constipation (IBS-C)",
      "Irritable Bowel Syndrome With Constipation, Chronic Constipation",
      "Irritable Bowel Syndrome With Constipation, Chronic Idiopathic Constipation",
      "Irritable Bowel Syndrome With Constipation, Functional Constipation",
      "Irritable Bowel Syndrome With Diarrhea (IBS-D)",
      "Irritable Bowel Syndrome with Constipation",
      "Opioid-Induced Constipation"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-12T09:44:19.818442",
    "search_query": "Ironwood Pharmaceuticals, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Ironwood+Pharmaceuticals,+Inc."
  }
}